$337.38
1.430.43%
At Close: -
$337.38
00.00%
After Hours: Sep 20, 4:39 PM EDT
15 minutes delayed
Amgen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amgen using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $4.97 | $5.00 | -0.60 % |
Mar 2024 | 2024-05-02 | $3.96 | $3.87 | 2.33 % |
Dec 2023 | 2024-02-06 | $4.71 | $4.62 | 1.95 % |
Sep 2023 | 2023-10-31 | $4.96 | $4.66 | 6.44 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $8.39B | $8.33B | 0.70 % |
Mar 2024 | 2024-05-02 | $7.45B | $6.94B | 7.31 % |
Dec 2023 | 2024-02-06 | $8.20B | $8.13B | 0.81 % |
Sep 2023 | 2023-10-31 | $6.90B | $6.94B | -0.59 % |
Amgen (AMGN) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $4.97, which missed the estimate of $5.00.
The Actual Revenue was $8.4B, which beat the estimate of $8.3B.
Browse earnings estimates, EPS, and revenue on all stocks.